# Spero Therapeutics, Inc.: Form 8-K, filed Feb 28, 2025

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: 8-K
- Filed: 2025-02-28
- Accepted by EDGAR: Feb 28, 2025, 17:11 ET
- Period: 2025-02-25
- Accession: 0001193125-25-042785
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312525042785/d924647d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312525042785/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312525042785/d924647d8k.htm

Filed Feb 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-042785. Last ingested by Listed: Nov 13, 2026, 16:27 ET. No prices; not investment advice.